Pischik, Elena http://orcid.org/0000-0003-2835-3927
Baumann, Katrin http://orcid.org/0000-0001-6444-0513
Karpenko, Alla http://orcid.org/0000-0001-7520-8031
Kauppinen, Raili http://orcid.org/0000-0002-8799-3425
Funding for this research was provided by:
Helsingin ja Uudenmaan Sairaanhoitopiiri
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 5 September 2022
Revised: 20 January 2023
Accepted: 22 January 2023
First Online: 9 February 2023
Declarations
:
: The authors EP, KB, RK have participated in clinical trials organised by Alnylam 2015–2020. EP and RK have been speakers in seminars organised by Orphan Europe and Alnylam and Medscape. RK and KB own stock in Orion pharmaceuticals company.
: This study was conducted in accordance with ethical principles of the Helsinki declaration and ethical issues were approved by the Consultative and Diagnostic Centre with Polyclinics, Saint Petersburg, Russia, and Helsinki University Hospital, Finland.